Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Obesity affects short-term folate pharmacokinetics in women of childbearing age

Abstract

Maternal folate status and body mass index (BMI) are independent risk factors for neural tube defects (NTD). Population-based studies have identified an inverse association between serum folate and BMI, after adjusting for intake. The objective of this intervention study was to compare the relationship between BMI and the short-term pharmacokinetic response to an oral dose of folic acid. Healthy obese (BMI 30.0 kg m−2; n=16) and normal-weight (BMI 18.5–24.9 kg m−2; n=16) women of childbearing age (18–35 years) were administered a single oral dose of folic acid (400 μg). Blood samples were collected over a 10-h period to evaluate the serum folate response. Fasting baseline serum folate was lower in the obese group (P=0.005); in contrast, red blood cell folate was higher (P=0.05). Area-under-the-curve for the absorption phase (0–3 h) and peak serum folate concentrations were lower in obese versus normal-weight women (P<0.005). Overall serum folate response (0–10 h) was lower in obese versus normal-weight women (repeated-measures ANOVA, P=0.001). Data suggest body distribution of folate is significantly affected by obesity, and, should pregnancy occur, may reduce the amount of folate available to the developing embryo. These findings provide additional support for a BMI-adjusted folic acid intake recommendation for NTD risk reduction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. China-U.S. Collaborative Project for Neural Tube Defect Prevention. Prevention of neural-tube defects with folic acid in China. N Engl J Med 1999; 341: 1485–1490.

    Article  CAS  Google Scholar 

  2. Czeizel AE, Dudas I . Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832–1835.

    Article  CAS  Google Scholar 

  3. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131–137.

    Article  Google Scholar 

  4. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J . Maternal obesity and risk of neural tube defects: a metaanalysis. Am J Obstet Gynecol 2008; 198: 611–619.

    Article  Google Scholar 

  5. Kim H, Hwang JY, Kim KN, Ha EH, Park H, Ha M et al. Relationship between body-mass index and serum folate concentrations in pregnant women. Eur J Clin Nutr 2012; 66: 136–138.

    Article  CAS  Google Scholar 

  6. Kimmons JE, Blanck HM, Tohill BC, Zhang J, Khan LK . Associations between body mass index and the prevalence of low micronutrient levels among US adults. Med Gen Med 2006; 8: 59.

    Google Scholar 

  7. Mahabir S, Ettinger S, Johnson L, Baer DJ, Clevidence BA, Hartman TJ et al. Measures of adiposity and body fat distribution in relation to serum folate levels in postmenopausal women in a feeding study. Eur J Clin Nutr 2008; 62: 644–650.

    Article  CAS  Google Scholar 

  8. Mojtabai R . Body mass index and serum folate in childbearing age women. Eur J Epidemiol 2004; 19: 1029–1036.

    Article  CAS  Google Scholar 

  9. Tinker SC, Hamner HC, Berry RJ, Bailey LB, Pfeiffer CM . Does obesity modify the association of supplemental folic acid with folate status among nonpregnant women of childbearing age in the United States? Birth Defects Res A Clin Mol Teratol 2012; 94: 749–755.

    Article  CAS  Google Scholar 

  10. Flegal KM, Carroll MD, Kit BK, Ogden CL . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012; 307: 491–497.

    Article  Google Scholar 

  11. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL . Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998; 22: 39–47.

    Article  CAS  Google Scholar 

  12. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP . The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999; 282: 1519–1522.

    Article  CAS  Google Scholar 

  13. Subar AF, Kirkpatrick SI, Mittl B, Zimmerman TP, Thompson FE, Bingley C et al. The Automated Self-Administered 24-hour dietary recall (ASA24): a resource for researchers, clinicians, and educators from the National Cancer Institute. J Acad Nutr Diet 2012; 112: 1134–1137.

    Article  Google Scholar 

  14. Tamura T . Microbiological assay of folate. In Picciano MF, Stokstad EL, Gregory JF (eds) Folic Acid Metabolism in Health and Disease. Wiley-Liss: New York, 1990. pp 121–137.

    Google Scholar 

  15. Horne DW, Patterson D . Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem 1988; 34: 2357–2359.

    CAS  PubMed  Google Scholar 

  16. Pentieva K, McNulty H, Reichert R, Ward M, Strain JJ, McKillop DJ et al. The short-term bioavailabilities of [6S]-5-methyltetrahydrofolate and folic acid are equivalent in men. J Nutr 2004; 134: 580–585.

    Article  CAS  Google Scholar 

  17. Prinz-Langenohl R, Bramswig S, Tobolski O, Smulders YM, Smith DEC, Finglas PM et al. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C -&gt; T polymorphism of methylenetetrahydrofolate reductase. Brit J Pharmacol 2009; 158: 2014–2021.

    Article  CAS  Google Scholar 

  18. Stern SJ, Matok I, Kapur B, Koren GA . Comparison of folic acid pharmacokinetics in obese and nonobese women of childbearing age. Ther Drug Monit 2011; 33: 336–340.

    Article  CAS  Google Scholar 

  19. Institute of Medicine. DRI Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press: Washington, DC, USA, 1998.

  20. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009; 123: 917–923.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by Georgia Experimental Agricultural Station, HATCH #GEO00706 and #GEO00707, and by the University of Georgia.

Author contributions

Study concept and design: da Silva, Hausman, Bailey; acquisition of data: da Silva, Hausman, Kauwell, Sokolow, Bailey; analysis and interpretation of data: da Silva, Hausman, Kauwell, Sokolow, Tackett, Rathbun, Bailey; drafting of the manuscript: da Silva, Hausman, Bailey; critical revision of the manuscript for important intellectual content: da Silva, Hausman, Kauwell, Sokolow, Tackett, Rathbun, Bailey; statistical analysis: da Silva, Rathbun; obtained funding: Bailey.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L B Bailey.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Silva, V., Hausman, D., Kauwell, G. et al. Obesity affects short-term folate pharmacokinetics in women of childbearing age. Int J Obes 37, 1608–1610 (2013). https://doi.org/10.1038/ijo.2013.41

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2013.41

Keywords

This article is cited by

Search

Quick links